the safety of Arava (leflunomide)
May 2002
There's growing concern over the safety of Arava (leflunomide).
An influential consumer group is asking the FDA to take Arava off the market in the U.S. In the last 5 years they've petitioned to ban Redux...Rezulin...Trovan...Lotronex...and Meridia.
Now they're going after Arava.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote